Homecare Expert under
New Frontier Group

Directors and Senior Advisors

• Dr. KO Wing-man, GBS, JP

  Director, New Frontier GBA Healthcare Group; Senior Advisor, New Frontier Group Limited

  Dr. Ko is the Director of New Frontier GBA Healthcare Group.

  
  

  Dr. Ko is a member of the Standing Committee of the National Committee of the Chinese People's Political Consultative Conference and the Standing Committee of the Chao Zhou City Committee of the Chinese People's Political Consultative Conference. Dr. Ko is also the Council Member of the Hong Kong Committee for UNICEF, Vice Chairman of the Federation of Hong Kong Chiu Chow Committee Organisations and Vice President of the Hong Kong China Chamber of Commerce. Dr. Ko was Secretary for Food and Health from July 2012 to June 2017 and was previously Chairman of the Hong Kong Anti-Cancer Society and Director of the Hong Kong Red Cross. He was awarded the Gold Bauhinia Star in 2017.

• Dr. Leong Che Hung, GBM, JP

  Director, New Frontier Health; Director, Strategic Healthcare Holding Limited

  Dr. Edward Leong Che-hung is a director of New Frontier Corporation. Dr. Leong is one of the most respected medical professionals and public health administrators in Asia, having actively engaged in public services and has engaged in various influential public roles during his career. He was a member of the Legislative Council of Hong Kong, representing the medical constituency from 1988 to 2000. In 2002, Dr. Leong was appointed as the chairman of the Hong Kong Hospital Authority where he was involved in drawing up the blueprint for Hospital Authority, taking special responsibility for Medical Service Development. Subsequently, Dr. Leong served as a non-official member of the Executive Council HKSAR from 2005 to 2012. He was chairman of the Hong Kong University Council until 2015 and spearheaded the commissioning of The University of Hong Kong – Shenzhen Hospital in Shenzhen during his term. Dr. Leong also served as the chairman of the Standard Working Hours Committee. His other former public positions include the Chairman of the Elderly Commission HKSAR, Chairman of Hong Kong AIDS Foundation and the Elder Academy Development Foundation. Dr. Leong was awarded the Gold Bauhinia Star in 2001 and the Grand Bauhinia Medal in 2010.

  
  

  Dr. Leong is a medical doctor in private practice specializing in Urology. After graduating from the University of Hong Kong in 1962, Dr. Leong worked in the Department of Surgery in Hong Kong University for 16 years. In addition to training medical students, Dr. Leong also conducted cutting-edge research in his specialist fields of urology. His major research contributions include experiments and the human use of the stomach for bladder replacement and urinary diversion. Dr. Leong was appointed Hunterian Professor by the Royal College of Surgeons of England in 1975. He was the first Hong Kong-born Chinese doctor to have received this accolade.

  
  

  Dr. Leong’s qualifications to serve on our board of directors include his extensive network and deep knowledge in the healthcare and education industries and his significant management experience in both the public and private sectors.

• Prof. Sophia Chan PRDHCE, MEd, MPH, PhD, RN, RSCN, FFPH, FAAN, GBS, JP

  Senior Advisor

  Professor Sophia Chan is currently the Senior Advisor to President’s Office at the University of Hong Kong, and the Professor and Director to HKU Primary Health Care Academy at the University of Hong Kong.

  
  

  Professor Sophia Chan was the Under Secretary for Food and Health of the Hong Kong SAR Government from 2012 to 2017 and the Secretary from 2017 to 2022. She is also the first nursing professor to hold a ministerial post.

  
  

  During her tenure, Professor Sophia Chan has formulated and promoted a number of medical, food and environmental health policies, including the establishment of the District Health Centers, the promotion of Chinese medicine and laying the foundation of Hong Kong's first Chinese medicine hospital, the opening of Hong Kong's first Children Hospital, the development of a cancer strategy and a plan for the prevention and control of Non-communicable diseases and the Implementation of Strategy and Action Plan on Anti-Microbial Resistance. In addition, Professor Sophia Chan also planned and established the Genome Research Institute, launched the Voluntary Health Insurance Scheme, and implemented a ban on E-cigarettes and Heated Tobacco Products in Hong Kong. In addition, during the epidemic, she led a number of policies and measures to combat COVID-19, contributing significantly to the stabilization and control of the epidemic in Hong Kong.

  
  

  Prior to her government service, Professor Sophia Chan was the Head of Department of Nursing Studies/School of Nursing of HKU and as Assistant Dean of the Li Ka Shing Faculty of Medicine.

  
  

  Professor Sophia Chan's academic background includes a Master of Education from the University of Manchester, a Master of Public Health from Harvard University and a Doctor of Philosophy from the University of Hong Kong.

  
  

  Professor Sophia Chan is a distinguished scientist in the fields of nursing and public health. She has focused her research on public health, management of tobacco dependency and prevention of second-hand smoke exposure in children, primary health care system and policy development, and has published over 240 scientific papers.

  
  

  Professor Sophia Chan has received a number of honors, including outstanding teaching award conferred by HKU, Honorary Fellow, Royal College of Physicians of United Kingdom, Fellow of the American Academy of Nursing, and Honorary Fellow of the Hong Kong College of Health Executives. She was also awarded the Gold Bauhinia Star in recognition of her contribution to public service. In addition, she received an Honorary Doctor of Social Science of the Metropolitan University, an Honorary Fellowship from the Hong Kong Academy of Nursing and an Outstanding Alumnus Award from the Hong Kong Polytechnic University.

• Prof. Diana Lee Tze Fan, JP

  Senior Advisor

  Professor Diana Lee is the Professor of Nursing at the Nethersole School of Nursing, Faculty of Medicine, The Chinese University of Hong Kong. She is also the Director ofY.K. Pao Foundation Centre for Nursing Excellence in Chronic Illness Care and theDeputy Director of CUHK Jockey Club Institute of Ageing. Professor Lee was the Former Chairman of the Nursing Council of Hong Kong and is a fellow of the American Academy of Nursing.

  
  

  Professor Lee's research interests lie in the areas of elderly health care and chronic illness care. She has been honored with the 'Excellent Research Award' by the Food and Health Bureau in 2007. Her research efforts are focused on promoting health-related quality of life for older people and patients with chronic illness, as well as on evaluating new initiatives for improving elderly health care services. In particular, she has conducted various studies to promote the

  
  

  quality of care in nursing homes. Recently, she is investigating end-of-life issues in nursing homes and in the community. She also led the territory-wide CADENZA training programme which was a HK$73.8 million funding programme to provide gerontological education and foster positive community attitudes towards aging.

  
  

  Professor Lee is dedicated to community service and has served on many government boards and councils. In recognition of her contributions to the community, she was appointed Justice of the Peace by the HKSAR Government in 2016.

• Dr. Dr. Antony Leung Chi Tat

  Senior Advisor

  Dr. Antony Leung graduated MBBS with distinction in Medicine from the University of Hong Kong and received postgraduate training in the Glasgow Royal Infirmary, Scotland. After obtaining specialist qualification in Advanced Internal Medicine and Nephrology, he was admitted as a fellow of the Royal College of Physicians & Surgeons of Glasgow as well as a founding fellow of the Hong Kong College of Physician. He had served as a clinical lecturer in the Faculty of Medicine in the Chinese University of Hong Kong and later on Hospital Chief Executive of the Haven of Hope Hospital.  He was among the first batch of specialists in Palliative Medicine in Hong Kong and is at present the Medical Superintendent of the Haven of Hope Sister Annie Skau Holistic Care Centre, a 100 beds independent hospice providing integrated End-of-Life care for the frail elders and patients with late stage chronic diseases. He has published over 50 articles in local and international journals on case management, elderly care, palliative care, spiritual care in End-of-Life and public health administration. He is also active in community service and was awarded the Bronze Bauhinia Star medal in 2017 by the Hong Kong SAR Government for his contribution in holistic End-of-Life care.

• Prof. Jean Woo

  Senior Advisor

  Professor Jean Woo obtained her medical degree From Cambridge University in 1974, and joined the Medical Faculty of the Chinese University of Hong Kong in 1985, being responsible for undergraduate and postgraduate training in Geriatric Medicine. She is also Honorary Consultant of the Hospital Authority, being responsible for the development of acute, non-acute and community geriatric services in the NT East region between 1993 and 2010.

  
  

  She is currently Emeritus Professor of Medicine, Henry G Leong Research Professor of Gerontology and Geriatrics, Director of the Jockey Club Institute of Aging at CUHK, the SH Ho Centre for Gerontology and Geriatrics, and the Centre for Nutritional Studies. She is actively engaged in pioneering novel models of community care of older people with the aid of technology, improving the quality of care at the end of life, strategies for healthy ageing, and healthcare training through empowerment.

• Prof. Tony Mok, BBS, BMSc, MD, FRCP(C), FRCP(Edin), FRCP(Lond), FHKCP, FHKAM(Medicine), FASCO, Member of ASHK

  Senior Advisor

  Professor Tony S.K. Mok was trained at the University of Alberta, Canada and he subsequently completed a fellowship in medical oncology at the Princess Margaret Hospital in Toronto. After working as a community oncologist in Toronto, Canada for seven years, he returned to Hong Kong in 1996 to pursue an academic career.

  
  

  Professor Mok is the Li Shu Fan Medical Foundation endowed Professor and Chairman of Department of Clinical Oncology at The Chinese University of Hong Kong. His main research interest focuses on biomarker and molecular targeted therapy in lung cancer. He was the Principal Investigator and first author on the landmark IRESSA® Pan-Asia Study (IPASS), which was the first study that confirmed the application of precision medicine for advanced lung cancer. He has also led and co-led multiple international phase III studies including the FASTACT 2, PROFILE 1014, IMPRESS, ARCHER 1050, ALEX, AURA 3 and KEYNOTE 042. These projects address various aspects on management of advanced lung cancer, and basically have defined the current practice. He dedicates his work on precision medicine for lung cancer by also engaging in clinical research on oncogene driven lung cancer and immunotherapy. His work has been adopted by multiple international guidelines including NCCN, AMP/IASLC/CAP, ASCO and ESMO. He also contributes to the development of clinical research infra-structure in China and Asia. He cofounded the Lung Cancer Research Group, Chinese Thoracic Oncology Research Group and Asia Thoracic Oncology Research Group.

  
  

  Professor Mok has contributed to over 315 articles in international peer-reviewed journals, including the New England Journal of Medicine, Science, Lancet, Nature Medicine and Journal of Clinical Oncology, and published multiple editorials and textbooks. He served as an Associate Editor for thoracic oncology for the Journal of Clinical Oncology and other international journals. He is the Past President, Past Treasurer of the International Association for the Study of Lung Cancer (IASLC) and Past Board of Director for ASCO. He is a member of the Board of Directors for AstraZeneca, Aurora Tele-Oncology, HutchMed (China), Insighta, St. Stephen’s College & Preparatory School Council and Hong Kong Academy of Sciences (ASHK). He is active in international education activity and has made significant contributions to AACR, ASCO, CSCO and ESMO. His work was recognized by numerous awards including Bonnie Addario Award in 2015, Fellowship of the American Society of Clinical Oncology (FASCO) in 2017, Paul 2020, Jr Scientific Award in 2017, National Science and Technology Progress Award in 2017, CSCO Annual Achievement Award in 2017, ESMO Lifetime Achievement Award in 2018, The 6th Kobayashi Foundation Award, Giant of Cancer Care 2020, SingTao Hong Kong Leader of the Year 2020 Award and The Sixth Fok Ying-Tung Prize The World Outstanding Chinese Doctor Award in 2023. His article in the New England Journal of Medicine has been selected as one of the most “Notable Articles in 2017”. He is one of the “Highly Cited Researchers” by Clarivate Analytics for five consecutive years from 2018 to 2023. He was awa rded with the Bronze Bauhinia Star (BBS) by the Government of Hong Kong Special Administrative Region in 2022 to recognize his dedicated service in public affairs.

• Prof. Yuen Kwok Yung, SBS, JP

  Senior Advisor

  MBBS(HK), MD(HK), FRCS(Glas), FRCPath(UK), FRCP(Edin & Lond)

  
  

  Henry Fok Professor in Infectious Diseases

  
  

  Chair of Infectious Diseases, Department of Microbiology

  
  

  Co-Director, State Key Laboratory of Emerging Infectious Diseases

  
  

  Academician, Chinese Academy of Engineering

  
  

  Professor Yuen is the Director of State Key Laboratory of Emerging Infectious Diseases at the University of Hong Kong (HKU) and the Service Director (Pathology) of Hong Kong West Cluster. He has discovered over 70 novel viruses, bacteria, fungi or parasitic species, many of which are named after HKU or Hong Kong. He played a key role in the discovery of the agent causing SARS, the SARS coronavirus and the animal reservoir, thus leading to measures that were crucial to containing the SARS outbreak. The HKSAR government has honoured his contributions with the award of a Silver Bauhinia Star in 2004. He was elected to the Chinese Academy of Engineering (Basic Medicine) in 2007.

  
  

  He is one of the world’s most highly cited researchers in the field of microbiology, as ranked by the Essential Science Indicator (ISI web), and has published more than 850 papers in international peer reviewed journals, with over 28,000 citations. His field of interest is novel microbes in emerging infectious disease outbreaks.

• Ms. Man Bo Lin, Manboo

  Senior Advisor

  Executive Director, Shenzhen New Frontier United Family Hospital; Senior Advisor, New Frontier Group

  
  

  Ms. Man Bo Lin is the Executive Director of Shenzhen New Frontier United Family Hospital.

  
  

  Ms. Man has over 50 years of experience in nursing and medical management. She graduated from the Queen Elizabeth Hospital School of Nursing and Midwifery in the 1970s, starting her nursing career. In her early years, she worked on the front lines of obstetrics, handling numerous emergency caesarean sections and umbilical cord prolapses, accumulating rich clinical experience. She later transitioned to management roles, serving as the Director of Nursing at Hong Kong Sanatorium & Hospital for many years, leading the team to enhance hospital service quality and promoting nursing education and training programmes.

  
  

  Ms. Man actively participates in medical quality improvement and was invited to serve as Co-Chair of the ACHSE QuIP4 Hong Kong Focus Group, promoting private hospital accreditation. She is also a member of various medical societies, such as the Federation of Medical Societies of Hong Kong (Family Medicine Committee), contributing to industry standard-setting and continuous professional development.

  
  

  Since joining New Frontier Group, Ms. Man has led the operations of Shenzhen New Frontier United Family Hospital, dedicated to integrating international medical standards with the needs of the Greater Bay Area to provide comprehensive family medical services. She has written articles sharing the transition from frontline to management, encouraging a new generation of nurses. Ms. Man is a Registered Nurse, and her passion for the medical profession and leadership experience make her an ideal board member.